Company intelligence / Profile preview

Formulex

Ness Ziona, Central, Israelformulex-pi.com ↗

Ownership: Private
Development stage: Commercial

Overview

Formulex has developed more than 10 medical cannabis products using its patented Solumer™ technology. Five of these are at clinical or commercial stages. The company specializes in innovative formulation solutions to improve solubility, bioavailability, and stability for challenging compounds across biopharma sectors. Pipeline details are limited publicly.

Therapeutic areas: Neurology
Modalities: Small moleculeCannabinoids
Industry: Biotech

Beyond the preview

Go deeper on Formulex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Formulex.

Explore the full profile